Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.

Lee HatterClaire HoughtonPepa BruceMark HollidayAllie EathorneIan PavordHelen K ReddelRobert J HancoxIrene Braithwaite Karen OldfieldAlberto PapiMark WeatherallRichard Beasleynull null

Published in: BMJ open respiratory research (2022)

There were no clinically important differences in the proportions of patients with 'well-controlled' or 'partly controlled' asthma symptoms, or proportions who improved or maintained their level of control, with as-needed budesonide-formoterol versus maintenance budesonide plus SABA.

Keyphrases

chronic obstructive pulmonary disease
lung function
cystic fibrosis
depressive symptoms
mesenchymal stem cells
bone marrow